Medicine
Tymlos 3.12 mg/1.56 mL injection
Tymlos 3.12 mg/1.56 mL injection is a prescription medicine containing Abaloparatide for subcutaneous use, marketed by Radius Health, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Before first use, store TYMLOS under refrigeration between 2°C to 8°C (36°F to…
Key facts
- Active ingredient (INN)
- Abaloparatide
- Brand
- Tymlos
- Strength
- 3.12 mg/1.56 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 cartridge of 1.56 mL
- Marketing authorisation holder
- Radius Health
- Manufacturer
- Radius Health
- Origin register
- US FDA, United States
- Storage
- Before first use, store TYMLOS under refrigeration between 2°C to 8°C (36°F to 46°F). Do not freeze or subject to heat. After first use, store for up to 30 days at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H05AA04 Abaloparatide
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 May 2017
- Identifiers
- RxCUI 1921075, 1921081DailyMed set ID 712143d9-e21e-4013-bb3b-3426a21060a8NDC 70539-001Application NDA208743
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 cartridge in 1 box, unit-dose / 1.56 mL in 1 cartridge | 70539-001-02 | Radius Health | 1 May 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Abaloparatide is a parathyroid hormone-related peptide analog indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy. MedsAcross supplies Abaloparatide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AbaloparatideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tymlos prescribing information (Radius Health) · U.S. National Library of Medicine, DailyMed
- Eladynos: European public assessment report (EPAR) · European Medicines Agency
Need Tymlos 3.12 mg/1.56 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.